Middleton, M.R. and Ranson, M. and Lee, S.M. and Bridgewater, J.A. (2006) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator and temozolomide. Clinical Cancer Research , 6 (Suppl.) 538a.
Full text not available from this repository.
|Title:||Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator and temozolomide|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Wolfson Institute and Cancer Institute Administration > Cancer Institute|
Archive Staff Only: edit this record